THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 99 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $296,000 | -40.1% | 10,628 | -26.3% | 0.03% | -40.4% |
| Q3 2017 | $494,000 | -14.1% | 14,428 | 0.0% | 0.05% | -23.5% |
| Q2 2017 | $575,000 | +8.3% | 14,428 | 0.0% | 0.07% | -4.2% |
| Q1 2017 | $531,000 | +7.9% | 14,428 | -6.5% | 0.07% | -29.7% |
| Q4 2016 | $492,000 | -26.3% | 15,428 | -16.3% | 0.10% | -16.5% |
| Q3 2016 | $668,000 | +157.9% | 18,428 | +61.3% | 0.12% | +146.9% |
| Q2 2016 | $259,000 | +20.5% | 11,428 | +1.6% | 0.05% | +25.6% |
| Q1 2016 | $215,000 | – | 11,248 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |